Reply to letter to the editor regarding "Optimal antithrombotic therapy for post-ischemic stroke patients with atrial fibrillation and atherosclerotic cardiovascular disease: A frequentist network meta-analysis"

Authors

• Ahmed Ibrahim, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
• Elsayed Balbaa, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
• Ameer Awashra, Department of Medicine, An Najah National University, Nablus, Palestine.
• Abdalhakim Shubietah, Advocate Health - MidwestFollow
• Giulia Cavolina, Azienda Ospedaliera Papardo, Messina, Italy; Department of Clinical and Experimental Medicine, University of Messina, Italy.
• Alessio Villari, Azienda Ospedaliera Papardo, Messina, Italy; Department of Clinical and Experimental Medicine, University of Messina, Italy.
• Giuseppe Andò, Azienda Ospedaliera Papardo, Messina, Italy; Department of Clinical and Experimental Medicine, University of Messina, Italy. Electronic address: giuseppe.ando@unime.it.
• Pierre Sabouret, Heart Institute and Action Group, Pitié-Salpétrière, Sorbonne University, 75013 Paris, France.

Recommended Citation

Ibrahim A, Balbaa E, Awashra A, et al. Reply to letter to the editor regarding "Optimal antithrombotic therapy for post-ischemic stroke patients with atrial fibrillation and atherosclerotic cardiovascular disease: A frequentist network meta-analysis". J Neurol Sci. Published online May 5, 2026. doi:10.1016/j.jns.2026.125977

Affiliations

Advocate Illinois Masonic Medical Center

Type

Letter

PubMed ID

42102642